×
About 74,085 results

ALLMedicine™ Pneumonia Center

Research & Reviews  23,614 results

Pneumocystis jirovecii Pneumonia in HIV-negative Patients, a Frequently Overlooked Prob...
https://doi.org/10.1016/j.ijid.2022.05.024
International Journal of Infectious Diseases : IJID : Off... Bozzi G, Saltini P et. al.

May 15th, 2022 - Pneumocystis jirovecii pneumonia (PCP) still has substantial morbidity and mortality. For non-HIV patients, course of infection is severe, and management guidelines relatively recent. We collected all PCP cases (EORTC criteria) diagnosed in HIV-ne...

Relationship between Aspiration Pneumonia and Feeding Care among Home Care Patients wit...
https://doi.org/10.3390/ijerph19095419
International Journal of Environmental Research and Publi... Hsiao SY, Yao CT et. al.

May 15th, 2022 - Home care patients have swallowing dysfunction and rely on an in-dwelling nasogastric tube (NGT) to complement oral food intake, supplement their diet, and maintain adequate nutritional status. This study explored the relationship between aspirati...

Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous ...
https://doi.org/10.1016/j.anl.2022.04.011
Auris, Nasus, Larynx; Ohara K, Katada A et. al.

May 15th, 2022 - A 15-year-old girl presented with a 3-year-history of continuous outflow of saliva from a pharyngocutaneous fistula, located at 5 mm superior to her tracheal stoma. She was diagnosed with Miller-Dieker syndrome at birth. At 2 years of age, pediatr...

Kinetics of inflammatory biomarkers to predict one-year mortality in elderly patients h...
https://doi.org/10.1016/j.ijid.2022.05.002
International Journal of Infectious Diseases : IJID : Off... Malézieux-Picard A, Nascè A et. al.

May 14th, 2022 - Long term mortality is increased in elderly patients with pneumonia. We aimed to test if residual inflammation is predictive of one-year mortality after pneumonia. Inflammation biomarkers (CRP, Interleukin (IL)-6 and -8, TNFα, Serum Amyloid A, Neo...

see more →

Guidelines  44 results

COVID-19: Update on Its Ocular Involvements, and Complications From Its Treatments and Vaccinations
https://pubmed.ncbi.nlm.nih.gov/34839344/
Asian-Pacific Journal of Ophthalmology; Lin TPH, Ko CN et. al.

Nov 24th, 2021 - The coronavirus disease 2019 (COVID-19) came under the attention of the international medical community when China first notified the World Health Organization of a pneumonia outbreak of then-unknown etiology in Wuhan in December 2019. Since then,...

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116237
Annals of Hematology; Classen AY, Henze L et. al.

Apr 14th, 2021 - Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new resear...

Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and tr...
https://doi.org/10.1016/j.parkreldis.2021.03.027
Parkinsonism & Related Disorders; Calandra-Buonaura G, Alfonsi E et. al.

Apr 12th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by a combination of autonomic failure plus cerebellar syndrome and/or parkinsonism. Dysphagia is a frequent and disabling symptom in MSA and its occurrence within 5 years ...

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

see more →

Drugs  1,280 results see all →

Clinicaltrials.gov  1,147 results

An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Are...
https://clinicaltrials.gov/ct2/show/NCT03908632

May 13th, 2022 - This is an observational study in 1,000 individuals aged 14 years or older, diagnosed with Community Acquired Pneumonia (CAP) who meet all eligibility criteria in Coccidioides endemic regions. This study is designed to provide data on the prevalen...

Study of Lung Proteins in Patients With Pneumonia
https://clinicaltrials.gov/ct2/show/NCT00077909

May 13th, 2022 - OBJECTIVE: The objective of this study is to analyze bronchoalveolar lavage (BAL) fluid from patients with lung infiltrates in order to discover new biomarkers and protein/peptide expression patterns that are associated with specific types of pulm...

Recruitment Maneuver After Bronchoalveolar Lavage in ARDS Patients
https://clinicaltrials.gov/ct2/show/NCT05372731

May 13th, 2022 - ARDS caused by pneumonia is one of the main reasons for ICU admission in critically ill patients, and also a common complication in patients admitted to ICU with invasive mechanical ventilation. Bronchoalveolar lavage (BAL) is the main diagnostic ...

Novel Experimental COVID-19 Therapies Affecting Host Response
https://clinicaltrials.gov/ct2/show/NCT04924660

May 12th, 2022 - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. The clinical spectrum of COVID-19 infection is broad, encompassing asymptomatic infection, mild ...

Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT02332577

May 12th, 2022 - The total study duration for each patient is 1 month with a treatment period of 7 to 9 days and a follow-up period of 21 to 23 days.

see more →

News  3,464 results

Nab-Paclitaxel Plus Pembrolizumab Produces Promising Responses in Advanced Urothelial Cancer
https://www.onclive.com/view/nab-paclitaxel-plus-pembrolizumab-produces-promising-responses-in-advanced-urothelial-cancer

May 2nd, 2022 - The combination of nab-paclitaxel (Abraxane) and pembrolizumab (Keytruda) produced an encouraging overall response rate (ORR) with manageable safety in patients with advanced urothelial cancer who were refractory to platinum-based chemotherapy or ...

Total Resection for Glioblastoma Predicts Longer Survival
https://www.medscape.com/viewarticle/972791

Apr 27th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Gross total resection is an independent predictor of longer survival and good postoperative functional recovery in...

Watch for Bacterial, Fungal Infections in COVID Patients in the ICU
https://www.medpagetoday.com/criticalcare/infectioncontrol/98411

Apr 26th, 2022 - In a small series from Ireland, patients in the intensive care unit (ICU) for severe COVID-19 were more likely to develop serious bacterial and fungal infections when they received the IL-6 inhibitor tocilizumab (Actemra), potentially reflecting t...

COVID-19 Again the Third-Leading Cause of US Deaths
https://www.medscape.com/viewarticle/972666

Apr 25th, 2022 - COVID-19 was the third-leading cause of death in the United States in 2021 for the second straight year, with only heart disease and cancer causing more deaths, the CDC said Friday. About 693,000 people died of heart disease in 2021, with 605,000 ...

European Approval Sought for Ivosidenib in IDH1-Mutated AML and Cholangiocarcinoma
https://www.onclive.com/view/european-approval-sought-for-ivosidenib-in-idh1-mutated-aml-and-cholangiocarcinoma

Apr 22nd, 2022 - A marketing authorization application (MAA) has been submitted to the European Medicines Agency (EMA) for 2 indications of ivosidenib (Tibsovo): in combination with azacitidine in the frontline treatment of patients with IDH1-mutated acute myeloid...

see more →

Patient Education  85 results see all →